Blood collection study for newly diagnosed HIV research
Part of Immune system & allergy, Infections clinical trials.
This research study collects blood cells from people recently diagnosed with HIV who haven't started HIV medicines yet. Researchers use these samples to understand how HIV affects the immune system and develop better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have been diagnosed with HIV
- You have not taken HIV medicines (antiretroviral therapy) in the last 6 months, or have very limited recent use
- Your blood pressure and heart rate are within safe ranges (blood pressure under 180/100, heart rate 50-100)
- Your blood cell counts meet minimum levels (hemoglobin at least 9.0, platelets at least 50,000)
- You have good veins for blood draws and can visit the clinic at least once in the next 4 months
- You are not pregnant, breastfeeding, or currently abusing alcohol or drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study collects blood cells from adults with HIV and their family members to understand why some people's immune systems control HIV better than others. Researchers will use your cells to study HIV immunity and develop better treatments.
This study tests how well researchers can track HIV-related health and immune changes over time by collecting blood and other samples. It may help you and your care team by creating detailed monitoring, even if your HIV diagnosis is new or still being evaluated.
This study measures how much HIV is in your blood and lymph node tissue. If you qualify, you would also allow blood and other tests (including genetic and hepatitis screening), which may help researchers better understand how HIV affects the body.
This research study examines how HIV works in the blood and body fluids of people with and without HIV. By studying blood samples, researchers hope to better understand HIV infection and develop better treatments.
This trial uses a special blood-removal procedure called apheresis to collect either plasma or white blood cells for laboratory research. It may help scientists understand infection or immune-related processes by providing specific blood components for study.
This study collects blood to help researchers run multiple projects, including comparing people who are HIV-negative with people who have HIV. It may help advance knowledge that could improve future testing or treatments.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.